AVAIL offers customized and cost-effective services for optimal development of new therapeutic candidates, vaccines, diagnostics and other pharmaceutical or biotechnology products. Our Section of Global Drug Development Support is strategically situated in the geographic heart of Europe and has global reach and capabilities through an international and multidisciplinary network of experts and suppliers. Our business model has been validated against top industry standards and ensures maximal flexibility and efficiency. The benefits resulting from the use of our customized development programs include early proof of concept, accelerated product registration, faster time to market uptake, and reduced costs.  Our tailor-made services meet a variety of different development needs and resources, and can suit an ample range of product owners, from start-ups or small biotechnology companies to large pharmaceutical corporations.